Conference Program
Dated 01.03.19
09:00 Rafi Gidron, IBT Founder and Chairman, Israel
09:05 Miri Polachek, CEO, Joy Ventures; IBT Founding Executive Director, Israel
09:10 Karin Mayer Rubinstein, CEO, IATI, Israel
Pear Therapeutics is leading development of a new treatment class known as prescription digital therapeutics, or PDTs. PDTs are designed to directly treat disease, tested for safety and efficacy in randomized clinical trials, evaluated by the FDA, and prescribed by healthcare providers. Dr. McCann will discuss this new treatment class and share recent developments across the portfolio, including the commercial launch of reSET, for the treatment of Substance Use Disorder, and reSET-O, for the treatment of Opioid Use Disorder. He will also provide a view into the company's pipeline, with PDTs in development across a range of serious diseases.
Corey McCann, President & CEO, Pear Therapeutics, USA
Posttraumatic Tetraplegia is a Life Changing Circumstance calling for major solutions to restore a minimal mobility to improve quality of life. We will discuss a new first in man global approach.
Moran Cerf, Professor, Neuroscience & Business, Kellogg School of Management, Northwestern University, USA
Alim Louis Benabid, Professor, Chairman of the Board, Clinatec; Member of the Academy of Sciences; Professor Emeritus of Biophysics at Joseph Fourier University; Scientific Advisor at the Atomic Energy Commission; Clinatec, Edmond J Safra Research Center, LETI-Minatec, France
Break
Subject to exploration in this session are the current and future technologies for deep brain stimulation. What is the possibility to use deep brain stimulation for disorders other than Parkinson or other movement disorders?
Chair: Zvi Israel, Director, Center for Functional and Restorative Surgery, Dept. of Neurosurgery, Hadassah Medical Center, Jerusalem
11:00 CLOSING THE LOOP ON PARKINSON'S DISEASE – FROM PHYSIOLOGY TO TREATMENT AND BACK
Hagai Bergman, Professor of Physiology, The Hebrew University of Jerusalem; President, Israel Society for Neuroscience (ISFN) (Israel)
11:15 NEURAL CO-PROCESSING: SHIFTING OUR MINDSET FROM MODULATING TO RESTORING DISEASED BRAIN CIRCUITS
Timothy Denison, Royal Academy of Engineering Chair in Emerging Technologies, Department of Engineering Science, Nuffield Department of Clinical Neuroscience, MRC Brain Network Dynamics Unit, Oxford University (UK)
11:30 PANEL DISCUSSION: WHAT IS THE BEST TECHNOLOGY FOR THE FUTURE DEEP BRAIN STIMULATION THERAPY?
• Hagai Bergman, Professor of Physiology, The Hebrew University of Jerusalem; President, Israel Society for Neuroscience (ISFN) (Israel)
• Timothy Denison, Royal Academy of Engineering Chair in Emerging Technologies, Department of Engineering Science, Nuffield Department of Clinical Neuroscience, MRC Brain Network Dynamics Unit, Oxford University (UK)
• Imad Younis, President, Alpha Omega
• Ziv Peremen, VP Medical Solutions, ElMindA
• Zvi Israel,Director, Center for Functional and Restorative Surgery, Dept. of Neurosurgery, Hadassah Medical Center, Jerusalem
Judges:
Eti Finkelstein, Merage Alumni Manager at Merage Institute
Amir Konigsberg, Co-Founder & Board Director of Twiggle; Board Member,Allegro.Ai
Sigal Yosef, Head of Life Science, Innovation and R&D Incentives Center, EY
Imad Younis, President, Alpha Omega
Finalists:
12:30 Genetika+
12:38 Nia Therapeutics, Inc
12:46 RenewSenses Ltd.
12:54 Wearable Devices Ltd.
13:02 NeuroIndex Ltd.
TECH DEMOS
13:15 – 13:20 Innosphere
REVOLUTIONIZING ADHD TREATMENT
Gabriel Shakour, Product manager, Innosphere (Israel)
13:20 – 13:30 Senso Medical
BIOPOT DEVELOPMENT KIT INTRODUCTION BY SENSOMEDICAL
A. Mark Mento, Marketing Director, Senso Medical (USA)
13:30 – 13:45 Alpha Omega
CLOSING THE LOOP IN DBS – PART 2
Omer Naor, PhD, Project manager, Alpha Omega Engineering, (Israel)
13:45 – 14:15 Vielight
PHOTOBIOMODULATION IS OPENING NEW OPPORTUNITIES FOR BRAIN STIMULATION
Lew Lim, PhD, DNM, MBA, Founder & CEO, VieLight (Canada)
The session explores the impact of Digital Health on the Brain Related healthcare. It will address the questions - what is preventing a more massive adoptions of Digital therapeutic technologies and what business models could work.
Chair: Anya Eldan, VP of the Israel Innovation Authority & Head of Startup Division, Israel
14:15 KEYNOTE LECTURE: GLIMPSE OF HEALTH RESEARCH AT GOOGLE
David Ben Shimol, MD, Health Technologies Lead, Research at Google, USA
14:35 PANEL DISCUSSION: DIGITAL BRAIN THERAPY – A REALITY?
• Anya Eldan, VP of the Innovation Authority and Head of Startup Division, Israel Innovation Authority, Israel
• Dan Shwarzman, CEO, MindUp, Israel
• Shlomo Mendlovic, CEO, Shalvata Mental Health Center, Israel
• Eran Harary, Senior Director, Global Clinical Development., Neuropsychiatry, Teva Pharmaceuticals Industries Ltd., Israel
• Dorit Sokolov, Managing Director, aMoon Fund, Israel
15:15 STARTUP SPOTLIGHT
15:15 Brainmarc
If You Can't Beat Them - Join Them; Digital Therapy for Social Anxiety
Nir Goren
CTO, Brainmarc, Israel
15:22 Neurolief
Fighting Migraine with Neuromodulation Digital Therapeutics
Eran Schenker
Dr., Chief Medical Innovation Officer, Neurolief, Israel
15:29 Novotalk
“Power to the patient” - disentangling the digital therapeutic delivery model
Zohar Beeri
Chairman & CEO, Novotalk, Israel
15:36 Train Pain
The future of digital health for treating pain-related brain plasticity
Elan Schneider
DPT, CEO & Co-Founder, Train Pain, Israel
15:43 EmotiPlay
Virtual Reality Therapy? Special people inspire special ideas
Noga Meir-Goren
Product manager, EmotiPlay, Israel
15:50 Viz.ai
Time=Brain, Automatic stroke detection and the next revolution in Healthcare
David Golan
Co-founder & CTO, Viz.ai, Israel
Break
Recent experimental and theoretical work provide new insights into the principles that govern the dynamics of neural systems and the processing of information. This session will discuss how ideas from basic research in neuroscience can be translated into reliable neurotechnologies.
Chair: Oren Shriki,Assistant Professor, Dept. of Cognitive and Brain Sciences and Dept. of Computer Science, Zlotowski Center for Neuroscience, Ben-Gurion University of the Negev, Israel
16:30 LIVING ON THE EDGE: ON CRITICAL BRAIN DYNAMICS AND ITS APPLICATIONS TO DIAGNOSING NEUROLOGICAL DISORDERS
Oren Shriki, Assistant Professor, Dept. of Cognitive and Brain Sciences and Dept. of Computer Science, Zlotowski Center for Neuroscience, Ben-Gurion University of the Negev, Israel
16:52 CLOSING THE CHASM: ACCELERATING TRANSLATIONAL NEUROSCIENCE APPLICATIONS THROUGH AUTOMATED BIOSIGNAL ANALYSIS IN THE CLOUD
Tim Mullen, PhD, Founder & CEO, Research Director, Intheon, USA
17:14 MEASURING PHYSIOLOGY AND BEHAVIOR IN YOUNG CHILDREN WITH AUTISM
Ilan Dinstein, Negev Autism Center, Ben-Gurion Universityof the Negev, Israel
17:36 TRANSLATIONAL NEUROREHABILITATION: DEFINITIONS, CHALLENGES AND OPPORTUNITIES. INTRODUCTION OF THE BGU-ALEH NEGEV INITIATIVE
Simona Bar-Haim, Founder, Step of Mind; Head, The laboratory for Motor Control and Rehabilitation of Walking, Ben-Gurion University of the Negev, Israel
Lior Shmuelof, Head, Brain & Action Lab, Ben-Gurion University of the Negev, Israel
Neurowellness is an emerging field focused on emotional wellbeing and resilience. There has been exponential growth in scientific research and technological developments dedicated to understanding and enhancing the human experience. The following two sessions will explore the science behind emotional wellbeing, showcase some of the latest technologies in the field and discuss how these technologies will reach the individual consumer to enhance our lives.
09:00 HERE’S FOR A BETTER MOOD: MEMORY, PREDICTION AND DEPRESSION
Moshe Bar
Prof., Director, Leslie and Susan Gonda Multidisciplinary Brain Research Center, Bar-Ilan University, (Israel)
09:25 CAN WE TRICK OUR BRAINS TO BE HEALTHY?
Talma Hendler
Prof., School of Psychological Science, Faculty of Medicine, Sagol School Neuroscience, Tel Aviv University; Director of the Sagol Brain Institute, Wohl Institute for Advanced Imaging, Tel Aviv Sourasky Medical Center (Israel)
Asya Rolls
Prof., HHMI-Wellcome International Scholar; Rappaport Institute for Medical Research; Technion, Israel Institute of Technology (Israel)
09:50 SPOTLIGHT ON APPLIED NEURO WELLNESS RESEARCH
Noam Sobel
Prof., Head, Department of Neurobiology, Weizmann Institute of Science (Israel)
Hadas Okon-Singer
PhD, Department of Psychology, Chair, Department of Cognitive Sciences
University of Haifa (Israel)
10:10 TRANSFORMATIVE TECHNOLOGIES FOR WELLBEING
Nichol Bradford
Executive Director and Co-Founder, The Transformative Technology Lab (USA)
11:00 THE STORY OF MUSE – BRINGING NEUROTECH TO CONSUMER BRAIN HEALTH
Ariel Garten
Founder and Chief Evangelism Officer at InteraXon, makers of Muse (Canada)
11:20 UNLEASHING JOY
Miri Polachek
CEO, Joy Ventures, (Israel)
11:30 PANEL DISCUSSION: THE FUTURE OF EMOTIONAL WELLBEING PRODUCTS
Moderator: Miri Polachek
CEO, Joy Ventures,(Israel)
Gilad Peleg
Co-founder & Chairman, Joy Ventures, (Israel)
Mike Edelhart
Managing Partner, Joyance Partners, (USA)
Benjamin Huerta
Director, Amdocs Guadalajara, (Mexico)
Nava Levit - Binnun
Director, Sagol Center for Brain and Mind; Founder & Director, Muda Institute for Mindfulness, Science and Society, Interdisciplinary Center (IDC) Herzliya, Israel
11:50 STARTUP SPOTLIGHT
Nanea Reeves
CEO, Co-Founder, TRIPP, Inc., (USA)
Aziz Kaddan
CEO, Myndlift,(Israel)
Tomer Aharonovitch
Co-Founder & CEO, NYX Technologies, (Israel)
Fotini Markopoulou
PhD, CEO, Doppel, (UK)
TECH DEMOS /Exhibition & Networking Area/
13:00 – 13:10 Myndlift
NEUROFEEDBACK FOR THE MASSES
Aziz Kaddan, CEO, Myndlift (Israel)
13:10 – 13:15 Excellent Brain
MAKING NEUROFEEDBACK ACCESSIBLE TO ALL
Merav Klo, CEO, Excellent Brain, (Israel)
13:15 – 13:20 Selfit Medical
SELFIT - DIGITAL THERAPY FOR NEUROLOGICAL DISORDERS
Shahar Figelman, CEO of Selfit Medical (Israel)
13:20 – 13:25 elminda
BRAIN NETWORKS ANALYTICS
Boaz Sadeh, Neuroscience Lead & Algorithm Developer, elminda (Israel)
13:25 – 13:35 ELSC
THE EDMOND AND LILY SAFRA CENTER FOR BRAIN SCIENCES (ELSC)
A MULTIDISCIPLINARY ACADEMIC HUB FOR BRAIN-TECH PARTNERSHIP, THE HEBREW UNIVERSITY OF JERUSALEM (ISRAEL)
Mickey London, The Hebrew University of Jerusalem (Israel)
BIOPOT DEVELOPMENT KIT HANDS-ON BY SENSO MEDICAL /Meeting Room 4/
13:00 – 14:00 Your platform for neuro technology development
The field of Artificial Intelligence takes inspiration from human intelligence and from the human brain. At the same time, Artificial Intelligence is utilized to better understand and serve the human brain, and ultimately improve people’s lives. This session will give an overview of activities at the forefront of the work being done in applying brain inspired technologies in industry and will also outline how these advancements are being applied to better understand the human brain.
Chair: Amir Konigsberg, Co-founder and Board Director of Twiggle Inc, Israel
14:00 HYBRID ML - COMBINING NETWORKS WITH WORLD KNOWLEDGE
Avinatan Hassidim,Research Group Lead, Google, Israel
14:22 ATTENTION: FROM COGNITIVE NEUROSCIENCE TO COMPUTER VISION
Nilli Lavie, Professor of Psychology and Brain Sciences and Director of the Attention and Cognitive Control laboratory at the University College London Institute of Cognitive Neuroscience, UK
14:44 FROM NEURAL NETWORKS TO DEEP LEARNING
Gal Chechik, Director of AI at NVIDIA, Associate Professor at the Gonda Brain Research Institute, Bar Ilan University, Israel
15:06 OPENING THE BLACK-BOX OF DEEP NEURAL NETWORKS: THE INFORMATION BOTTLENECK THEORY OF DEEP LEARNING
Naftali Tishby, Professor, Computer Science, The Hebrew University; Member of the Edmond and Lilly Safra Center for Brain Sciences (ELSC), Hebrew University, Israel
Real life case studies from clinicians and hospital researches of attempts at integrating neuro-tech in the medical world - what works and what doesn't? What is needed and is the hype around current technologies justified?
Chair: Dana Gefen Doron, Neurorehabilitation specialist, Senior Physician, Stroke Unit,, Sheba Medical Center, Israel
16:00 INCORPORATING CUTTING EDGE TECHNOLOGIES IN FUNCTIONAL NEUROSURGERY
Ido Strauss, Director, Neuromodulation Unit, Department of Neurosurgery, Tel Aviv Sourasky Medical Center, Israel
16:15 REAL WORLD CHALLENGES TO PREDICTION OF PSYCHIATRIC DISORDERS
Avraham Reichenberg, Professor of Preventive Medicine and Psychiatry at the Ichan School of Medicine at Mount Sinai in New York; Senior Fellow of the Seaver Center for Autism Research and Treatment, New York, USA
16:30 HOW THE STARTUP NATION MAY BECOME THE NATION THAT WILL PREVENT ALZHEIMER’S DISEASE?
Michal Beeri, Director of the Sagol Neuroscience Research Center, Sheba Medical Center, Israel
16:45 THE OBSTACLES IN ADOPTING NEW TECHNOLOGIES IN NEURO-MEDICINE
Gili Givaty, Neurologist, Deputy Director of Barzilai Medical Center, Israel
BrainMind is an ecosystem and platform for impact-oriented company creation in brain and mind science. Brain science is in the midst of a transformative step change in capacity, akin to the sequencing of the human genome in genetics or development of nuclear fission in physics. Emerging technologies with unprecedented ability to access and manipulate the brain and mind are being rapidly developed in the private sector, where public oversight is limited. As a species, we must proactively navigate this watershed era in neuroscience. The BrainMind ecosystem will catalyze impact-maximizing innovation in brain science with new forms of capital and leadership support for non-venture-backable ideas with the most potential to benefit humanity. Less than a year old, the platform has attracted Stanford, MIT, and Oxford and a growing list of academic collaborators. BrainMind’s leaders Michael McCullough, Ed Boyden, Laura Roberts, and Reid Hoffman have leveraged the private sector to draw together top philanthropists/foundations (>$100BN in capital), and the world’s top investors and entrepreneurs in this ecosystem to support these pivotal ideas from the lab to society.
Michael McCullough, Entrepreneur In Residence at Greylock Partners, Founder & President of BrainMind & QuestBridge, & Asst Professor of Emergency Medicine at UCSF, USA